temferon
temferon: 2 clinical trials tracked.
temferon evidence translation
What we can confirm
2 tracked trials
What it means
What to watch
Prepared research question
What is verified about temferon, and what remains unknown?
Traceable citations · Unknowns marked
See linked entities and source evidence1 indications · 0 study sponsors
Related indications
Study sponsors
No additional listed-company sponsor is linked.
Clinical Trial Registry Records (2)
An Open-label Phase 1/2 Study to Evaluate the Safety, Biological Response and Efficacy of a Single Dose of Temferon (Autologous CD34+-Enriched Hematopoietic Stem and Progenitors Cells Genetically Modified With Human Interferon-α2) in Patients With Metastatic Renal Cell Carcinoma
Primary endpoint: Tolerability and safety of conditioning and Temferon, over the first 90 days following administration, as determined by the incidence of adverse events
A Phase I/IIa Dose Escalation Study Evaluating the Safety and Efficacy of Autologous CD34+-Enriched HSPCs Genetically Modified With Human Interferon-α2 in Patients With Glioblastoma Multiforme and Unmethylated MGMT Gene Promoter
Primary endpoint: Tolerability and safety of Temferon over the first 90 days following administration as determined by the incidence of adverse events